0000899749-21-000089.txt : 20210603 0000899749-21-000089.hdr.sgml : 20210603 20210603162144 ACCESSION NUMBER: 0000899749-21-000089 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20210601 ITEM INFORMATION: Entry into a Material Definitive Agreement FILED AS OF DATE: 20210603 DATE AS OF CHANGE: 20210603 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HEALTHCARE REALTY TRUST INC CENTRAL INDEX KEY: 0000899749 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] IRS NUMBER: 621507028 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11852 FILM NUMBER: 21992772 BUSINESS ADDRESS: STREET 1: 3310 WEST END AVE STREET 2: FOURTH FL SUITE 700 CITY: NASHVILLE STATE: TN ZIP: 37203 BUSINESS PHONE: 6152698175 MAIL ADDRESS: STREET 1: 3310 WEST END AVENUE, SUITE 700 CITY: NASHVILLE STATE: TN ZIP: 37203 8-K 1 hr-20210601.htm 8-K hr-20210601
0000899749false00008997492021-06-032021-06-03

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 8-K

CURRENT REPORT
Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934

    Date of report (Date of earliest event reported): June 3, 2021 (June 1, 2021)


HEALTHCARE REALTY TRUST INCORPORATED
(Exact Name of Registrant as Specified in Charter)
Maryland001-1185262-1507028
(State or other jurisdiction of incorporation)(Commission File Number)(I.R.S. Employer
Identification No.)

3310 West End Avenue, Suite 700
Nashville, Tennessee 37203
(Address of principal executive offices)
(615) 269-8175
(Registrant's telephone number, including area code)

Not Applicable
(Former name or former address, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common stock, $0.01 par value per shareHRNew York Stock Exchange

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.




Item 1.01 Entry into a Material Definitive Agreement.

On June 1, 2021, Healthcare Realty Trust Incorporated (the "Company") entered into a Second Amendment to the Amended and Restated Term Loan by and among the Company, as borrower, Wells Fargo Bank, National Association, as administrative agent, PNC Bank, National Association and U.S. Bank National Association, as syndication agents, and the other lenders that are party thereto (the "Amendment"). The Amendment amends the Amended and Restated Term Loan, dated May 31, 2019 (the "Term Loan") by converting the $150 million Tranche B Term Loan (as defined in the Term Loan) from a seven-year term loan to a five-year term loan and reducing the current interest rate (based on the Company's credit ratings) from LIBOR plus 1.60% to LIBOR plus 0.95%. The original maturity date remains the same at June 1, 2026. The Company paid approximately $508,000 in lender and legal fees in connection with the Amendment.

In addition, the Amendment provides for an "ESG" incentive for the Company to achieve certain sustainability targets that are based on the percentage of the Company's properties that hold certifications from third-party environmental certifiers, including LEED, IREM, CSP, ENERGY STAR, and other similarly recognized third-party green building certifications. If the Company meets these targets, the spread over LIBOR for the Tranche B Term Loan will be reduced by 0.01%. All other terms under the Term Loan remain in effect.


Item 9.01        Financial Statements and Exhibits
104     Cover Page Interactive Data File (embedded within the Inline XBRL document)

















SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
HEALTHCARE REALTY TRUST INCORPORATED
By:/s/ J. Christopher Douglas
J. Christopher Douglas
Executive Vice President - Chief Financial Officer
June 3, 2021


EX-10.1 2 secondamendmenttoamendedan.htm EX-10.1 Document
Exhibit 10.1
Execution Version

SECOND AMENDMENT TO AMENDED AND RESTATED TERM LOAN AGREEMENT

This SECOND AMENDMENT TO AMENDED AND RESTATED TERM LOAN AGREEMENT (this “Amendment”) dated as of June 1, 2021 by and among HEALTHCARE REALTY TRUST INCORPORATED, a corporation formed under the laws of the State of Maryland (the “Borrower”), each of the Lenders party hereto and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Administrative Agent (the “Administrative Agent”).

WHEREAS, the Borrower, the Lenders, the Administrative Agent and certain other parties have entered into that certain Amended and Restated Term Loan Agreement dated as of May 31, 2019 (as amended and as in effect immediately prior to the effectiveness of this Amendment, the “Credit Agreement”); and

WHEREAS, the Borrower, the Lenders and the Administrative Agent desire to amend certain provisions of the Credit Agreement on the terms and conditions contained herein.

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged by the parties hereto, the parties hereto agree as follows:

Section 1. Amendment to Credit Agreement. Effective as of June 1, 2021, the parties hereto agree that the Credit Agreement is hereby amended as follows:

(a) Section 1.01 of the Credit Agreement is hereby amended by deleting the definition of “Applicable Percentage” in its entirety and inserting the following new definition in lieu thereof:

Applicable Percentage” means, for any day, the rate per annum set forth below opposite the applicable Debt Rating for the applicable Class of Loans:

Pricing Level
Debt Ratings
(or their equivalents)
Tranche A Eurodollar Rate Loans
Tranche A Base Rate Loans
Tranche B Eurodollar Rate Loans
Tranche B Base Rate Loans
Commitment Fee
1
A-/A3 or better
0.85%
0.85%
0.80%
0.80%
0.125%
2
BBB+/Baa1
0.90%
0.90%
0.85%
0.85%
0.150%
3
BBB/Baa2
1.00%
1.00%
0.95%
0.95%
0.200%
4
BBB-/Baa3
1.25%
1.25%
1.20%
1.20%
0.250%
5
BB+/Ba1 and below
1.65%
1.65%
1.60%
1.60%
0.300%

The Borrower will maintain a Debt Rating at all times with at least two (2) Ratings Services, and the Borrower may, at its option, obtain a third Debt Rating from another Ratings Service. The applicable Pricing Level will be determined by reference to the Debt Ratings; provided that:

(a) if Debt Ratings are provided by two (2) Ratings Services and the Debt Ratings by the Rating Services indicate different Pricing Levels, then (A) if they are only one level apart, the applicable Pricing Level shall be determined by reference to the higher or better Debt Rating and shall be set at the Pricing Level indicated thereby, and (B) if they are more than one level apart, the applicable Pricing Level shall be determined by reference to the lower (or worse) Debt Rating and shall be set at one Pricing Level above the Pricing Level that would be indicated by the lower Debt Rating (e.g., if the Debt Rating by one of the Rating Services is A- and the Debt Rating by another of the Rating Services is Baa3, the Applicable Percentage would be set at Pricing Level 3),




(b) if Debt Ratings are provided by three (3) or more Ratings Services acceptable to the Administrative Agent and the Debt Ratings indicate different Pricing Levels, then the applicable Pricing Level shall be determined by reference to the lower of the two (2) highest (or best) Debt Ratings and shall be set at the Pricing Level indicated thereby, and

(c) if a Debt Rating is not provided by at least two (2) Ratings Services, or if no Debt Rating is available, then the Applicable Percentage shall be Pricing Level 5.

The Applicable Percentage shall be determined and adjusted on the first Business Day following the date of any change in the Debt Rating. Adjustments in the Applicable Percentage shall be effective as to all Loans from the date of adjustment. Determinations by the Administrative Agent of the applicable Pricing Level shall be conclusive absent manifest error. The Administrative Agent shall promptly notify the Lenders of changes in the Applicable Percentage.

Notwithstanding the foregoing, if at the end of any fiscal year the Borrower meets the Sustainability Metric Percentage (as defined below) for such fiscal year, then from and after the fifth (5th) Business Day following the date the Borrower provides to the Administrative Agent a notice (the “Sustainability Grid Notice”) that the Sustainability Metric Percentage for such fiscal year was satisfied, the Applicable Percentage shall decrease by 0.01% (but not to below zero percent per annum) from the Applicable Percentage that would otherwise be applicable; provided that (x) at no time shall the reduction in the Applicable Percentage resulting from the delivery of the Sustainability Grid Notice exceed 0.01% and (y) on each anniversary of such change to the Applicable Percentage, the Applicable Percentage shall automatically revert to the original grid set forth above unless and until the Borrower delivers a Sustainability Grid Notice to the Administrative Agent indicating that the Sustainability Metric Percentage for the preceding fiscal year has been satisfied. Each party hereto hereby agrees that the Administrative Agent shall not have any responsibility for (or liability in respect of) reviewing, auditing or otherwise evaluating any calculation by the Borrower of any Sustainability Metric Percentage or any Sustainability Metric (or any of the data or computations that are part of or related to any such calculation) set forth in any Sustainability Grid Notice. The Administrative Agent may rely conclusively on any Sustainability Grid Notice delivered by the Borrower without any responsibility to verify the accuracy thereof.

(b) Section 1.01 of the Credit Agreement is hereby amended by inserting the following new defined terms in correct alphabetical order:


2020 Baseline” means the Sustainability Metric for the fiscal year ended December 31, 2020, which is 1.8%.

Qualifying Property” means a property identified by the Borrower on its portfolio schedule or other similar schedule in its quarterly supplemental report which is a real estate asset owned by the Borrower, any Subsidiary, or through the Borrower’s unconsolidated joint venture with Teachers Insurance and Annuity Association.

Sustainability Metric” means, collectively, for any fiscal year, the number of Qualifying Properties which have current/active ENERGY STAR, LEED, IREM, CSP, or other similarly recognized third-party green building certifications as a percentage (rounded to one decimal point) of the total number of Qualifying Properties.




Sustainability Metric Percentage” means the level of growth in the Sustainability Metric specified in the table below for the applicable fiscal year from the 2020 Baseline as shown in the table below; the Sustainability Metric Percentage for each fiscal year shall be determined as of December 31 of such fiscal year.
Fiscal Year
Sustainability Metric Percentage
2021
2020 Baseline plus 2.0%
2022
2020 Baseline plus 4.0%
2023
2020 Baseline plus 6.0%
2024
2020 Baseline plus 7.5%
2025
2020 Baseline plus 9.0%

Section 2. Conditions Precedent. The effectiveness of this Amendment is subject to receipt by the Administrative Agent of each of the following in form and substance satisfactory to the Administrative Agent:

(a) a counterpart of this Amendment duly executed by the Borrower, the Administrative Agent and each of the Tranche B Term Facility Lenders;

(b) no Default or Event of Default shall exist or shall occur as a result of this Amendment;

(c) the Administrative Agent shall have received and reviewed, with results satisfactory to the Administrative Agent and its counsel, information regarding litigation, tax, accounting, labor, insurance, pension liabilities (actual or contingent), real estate leases, material contracts, debt agreements, property ownership, environmental matters, contingent liabilities and management of the Borrower and its Subsidiaries;

(d) a certificate of the Borrower, signed on behalf of the Borrower by the Borrower’s chief executive officer or chief financial officer, certifying that, (i) since December 31, 2020, there has not been a material adverse change in the condition (financial or otherwise), operations, business, assets, liabilities or prospects of the Consolidated Group taken as a whole or in the facts and information regarding such entities as represented to date, nor has there been a downgrade of the Borrower’s credit rating of two or more notches, and (ii) there is no action, suit, investigation or proceeding pending or threatened in any court or before any arbitrator or governmental authority that purports (x) to materially and adversely affect the Borrower or its subsidiaries, or (y) to affect any transaction contemplated by or under the Credit Agreement or the ability of the Borrower and its subsidiaries or any other obligor under the guarantees to perform their respective obligations under the Credit Agreement;

(e) the Borrower and each other Credit Party shall have provided all information requested by the Administrative Agent and each Lender in order to comply with applicable “know your customer” and anti-money laundering rules and regulations, including without limitation, the Patriot Act;

(f) evidence that all fees and expenses due and payable to the Administrative Agent, any of the Lenders and any of their respective Affiliates have been paid; and

(g) such other documents, agreements and instruments as the Administrative Agent may reasonably request.

Section 3. Representations. The Borrower represents and warrants to the Administrative Agent and the Lenders that:




(a) Corporate and Governmental Authorization; No Contravention. The execution and delivery by the Borrower of this Amendment and the performance by the Borrower of its obligations hereunder and under the Credit Agreement as amended by this Amendment are within the corporate power of the Borrower, have been duly authorized by all necessary corporate action, require no action by or in respect of, or filing with, any governmental body, agency or official or other Person (except for any such action or filing that has been taken and is in full force and effect) and do not contravene, or constitute a default under, any provision of applicable law or regulation or of the Organization Documents of the Borrower or of any material agreement, judgment, injunction, order, decree or other material instrument binding upon the Borrower or result in the creation or imposition of any Lien on any asset of the Borrower other than Liens created pursuant to the Credit Documents.

(b) Binding Effect. This Amendment and the Credit Agreement as amended by this Amendment constitute valid and binding agreements of the Borrower, enforceable against the Borrower in accordance with their terms.

(c) No Default. No Default or Event of Default has occurred and is continuing as of the date hereof nor will exist immediately after giving effect to this Amendment.

Section 4. Reaffirmation of Representations. The Borrower hereby repeats and reaffirms all representations and warranties made by the Borrower to the Administrative Agent and the Lenders in the Credit Agreement as amended by this Amendment and the other Credit Documents on and as of the date hereof with the same force and effect as if such representations and warranties were set forth in this Amendment in full.

Section 5. Certain References. Each reference to the Credit Agreement in any of the Credit Documents shall be deemed to be a reference to the Credit Agreement as amended by this Amendment. This Amendment is a Credit Document.

Section 6. Costs and Expenses. The Borrower shall reimburse the Administrative Agent for all reasonable out-of-pocket costs and expenses (including Attorney Costs) incurred by the Administrative Agent in connection with the preparation, negotiation and execution of this Amendment and the other agreements and documents executed and delivered in connection herewith.

Section 7. Benefits. This Amendment shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors and assigns.

Section 8. GOVERNING LAW. THIS AMENDMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES UNDER THIS AMENDMENT SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK (WITHOUT TAKING INTO ACCOUNT CONFLICT OF LAW PRINCIPLES THAT WOULD RESULT IN THE APPLICATION OF THE LAW OF ANOTHER JURISDICTION).

Section 9. Effect; Ratification. Except as expressly herein amended, the terms and conditions of the Credit Agreement and the other Credit Documents remain in full force and effect. The amendments contained herein shall be deemed to have prospective application only. The Credit Agreement is hereby ratified and confirmed in all respects. Nothing in this Amendment shall limit, impair or constitute a waiver of the rights, powers or remedies available to the Administrative Agent or the Lenders under the Credit Agreement or any other Credit Document.




Section 10. Counterparts. This Amendment may be executed in any number of counterparts, each of which shall be deemed to be an original and shall be binding upon all parties, their successors and assigns.

Section 11. Definitions. All capitalized terms not otherwise defined herein are used herein with the respective definitions given them in the Credit Agreement.

[Signatures on Next Page]




IN WITNESS WHEREOF, the parties hereto have caused this Second Amendment to Amended and Restated Term Loan Agreement to be executed as of the date first above written.



HEALTHCARE REALTY TRUST INCORPORATED
By:/s/ B. Douglas Whitman II
Name:B. Douglas Whitman II
Title:SVP, Finance & Treasurer
























[Signatures Continued on Next Page]













[Signature Page to Second Amendment to Amended and Restated Term Loan Agreement for Healthcare Realty Trust Incorporated]


Wells Fargo Bank, National Association, as Administrative
Agent and as a Tranche B Term Facility Lender
By:/s/ Matthew Kuhn
Name:Matthew Kuhn
Title:Director






















[Signatures Continued on Next Page]



















[Signature Page to Second Amendment to Amended and Restated Term Loan Agreement for Healthcare Realty Trust Incorporated]


PNC BANK, Nation Association, as a Tranche B
Term Facility Lender
By:/s/ Andrew T. White
Name:Andrew T. White
Title:Senior Vice President

























[Signatures Continued on Next Page]















[Signature Page to Second Amendment to Amended and Restated Term Loan Agreement for Healthcare Realty Trust Incorporated]


U.S. BANK NATIONAL ASSOCIATION, as a Tranche B
Term Facility Lender
By:/s/ Lori Y. Jensen
Name:Lori Y. Jensen
Title:Senior Vice President


























[Signatures Continued on Next Page]













[Signature Page to Second Amendment to Amended and Restated Term Loan Agreement for Healthcare Realty Trust Incorporated]


BANK OF MONTREAL, as a Tranche B Term Facility
Lender
By:/s/ Jonas L. Robinson
Name:Jonas L. Robinson
Title:VP
























[Signatures Continued on Next Page]












[Signature Page to Second Amendment to Amended and Restated Term Loan Agreement for Healthcare Realty Trust Incorporated]


FIFTH THIRD BANK, NATIONAL ASSOCIATION as a
Tranche B Term Facility Lender
By:/s/ Michael P. Perillo
Name:Michael P. Perillo
Title:Executive Director
























[Signatures Continued on Next Page]

















[Signature Page to Second Amendment to Amended and Restated Term Loan Agreement for Healthcare Realty Trust Incorporated]


TRUIST BANK, as a Tranche B Term Facility
Lender
By:/s/ Brad Bowen
Name:Brad Bowen
Title:Managing Director

























[Signatures Continued on Next Page]

















[Signature Page to Second Amendment to Amended and Restated Term Loan Agreement for Healthcare Realty Trust Incorporated]


FIRST HORIZON BANK, as a Tranche B Term Facility Lender
By:/s/ Cairy Wind
Name:Cairy Wind
Title:SVP

























[Signatures Continued on Next Page]

















[Signature Page to Second Amendment to Amended and Restated Term Loan Agreement for Healthcare Realty Trust Incorporated]


PINNACLE BANK, as a Tranche B Term Facility
Lender
By:/s/ Todd Carter
Name:Todd Carter
Title:Senior Vice President

























[Signatures Continued on Next Page]

















[Signature Page to Second Amendment to Amended and Restated Term Loan Agreement for Healthcare Realty Trust Incorporated]


ASSOCIATED BANK, NATIONAL ASSOCIATION as a
Tranche B Term Facility Lender
By:/s/ Mitchell Vega
Name:Mitchell Vega
Title:Senior Vice President


























[Signatures Continued on Next Page]















[Signature Page to Second Amendment to Amended and Restated Term Loan Agreement for Healthcare Realty Trust Incorporated]

UNITED BANK, as a Tranche B Term Facility Lender
By:/s/ Frederick H. Denecke
Name:Frederick H. Denecke
Title:Senior Vice President
























[Signatures Continued on Next Page]





















[Signature Page to Second Amendment to Amended and Restated Term Loan Agreement for Healthcare Realty Trust Incorporated]


FIRST FINANCIAL BANK, as a Tranche B Term
Facility Lender
By:/s/ John Wilgus
Name:John Wilgus
Title:Senior Vice President

























EX-101.SCH 3 hr-20210601.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover Page Document link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 hr-20210601_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Written Communications Written Communications Pre-commencement Tender Offer Pre-commencement Tender Offer Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, City or Town Entity Address, City or Town Soliciting Material Soliciting Material Entity Address, Address Line One Entity Address, Address Line One Security Exchange Name Security Exchange Name City Area Code City Area Code Entity Tax Identification Number Entity Tax Identification Number Entity File Number Entity File Number Document Type Document Type Entity Central Index Key Entity Central Index Key Entity Emerging Growth Company Entity Emerging Growth Company Title of 12(b) Security Title of 12(b) Security Local Phone Number Local Phone Number Entity Address, State or Province Entity Address, State or Province Amendment Flag Amendment Flag Entity Address, Postal Zip Code Entity Address, Postal Zip Code Trading Symbol Trading Symbol Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Cover Page [Abstract] Cover Page [Abstract] Cover Page [Abstract] Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name EX-101.PRE 5 hr-20210601_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 6 hr-20210601_htm.xml IDEA: XBRL DOCUMENT 0000899749 2021-06-03 2021-06-03 0000899749 false 8-K 2021-06-01 HEALTHCARE REALTY TRUST INCORPORATED MD 001-11852 62-1507028 3310 West End Avenue, Suite 700 Nashville TN 37203 615 269-8175 Common stock, $0.01 par value per share HR NYSE false false false false false XML 7 R1.htm IDEA: XBRL DOCUMENT v3.21.1
Cover Page Document
Jun. 03, 2021
Cover Page [Abstract]  
Title of 12(b) Security Common stock, $0.01 par value per share
Entity Central Index Key 0000899749
Amendment Flag false
Document Type 8-K
Document Period End Date Jun. 01, 2021
Entity Registrant Name HEALTHCARE REALTY TRUST INCORPORATED
Entity Incorporation, State or Country Code MD
Entity File Number 001-11852
Entity Tax Identification Number 62-1507028
Entity Address, Address Line One 3310 West End Avenue, Suite 700
Entity Address, City or Town Nashville
Entity Address, State or Province TN
Entity Address, Postal Zip Code 37203
City Area Code 615
Local Phone Number 269-8175
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Trading Symbol HR
Security Exchange Name NYSE
EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.1 html 1 95 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Cover Page Document Sheet http://healthcarerealty.com/role/CoverPageDocument Cover Page Document Cover 1 false false All Reports Book All Reports hr-20210601.htm hr-20210601.xsd hr-20210601_lab.xml hr-20210601_pre.xml secondamendmenttoamendedan.htm http://xbrl.sec.gov/dei/2019-01-31 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "hr-20210601.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "hr-20210601.htm" ] }, "labelLink": { "local": [ "hr-20210601_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "hr-20210601_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "hr-20210601.xsd" ], "remote": [ "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "hr", "nsuri": "http://healthcarerealty.com/20210601", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hr-20210601.htm", "contextRef": "i16da23a44288498db907d28cf173609b_D20210603-20210603", "decimals": null, "first": true, "lang": "en-US", "name": "dei:Security12bTitle", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover Page Document", "role": "http://healthcarerealty.com/role/CoverPageDocument", "shortName": "Cover Page Document", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hr-20210601.htm", "contextRef": "i16da23a44288498db907d28cf173609b_D20210603-20210603", "decimals": null, "first": true, "lang": "en-US", "name": "dei:Security12bTitle", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthcarerealty.com/role/CoverPageDocument" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthcarerealty.com/role/CoverPageDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthcarerealty.com/role/CoverPageDocument" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthcarerealty.com/role/CoverPageDocument" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthcarerealty.com/role/CoverPageDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthcarerealty.com/role/CoverPageDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthcarerealty.com/role/CoverPageDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthcarerealty.com/role/CoverPageDocument" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthcarerealty.com/role/CoverPageDocument" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthcarerealty.com/role/CoverPageDocument" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthcarerealty.com/role/CoverPageDocument" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthcarerealty.com/role/CoverPageDocument" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthcarerealty.com/role/CoverPageDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthcarerealty.com/role/CoverPageDocument" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthcarerealty.com/role/CoverPageDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthcarerealty.com/role/CoverPageDocument" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthcarerealty.com/role/CoverPageDocument" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthcarerealty.com/role/CoverPageDocument" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthcarerealty.com/role/CoverPageDocument" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthcarerealty.com/role/CoverPageDocument" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthcarerealty.com/role/CoverPageDocument" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://healthcarerealty.com/role/CoverPageDocument" ], "xbrltype": "booleanItemType" }, "hr_CoverPageAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover Page [Abstract]", "label": "Cover Page [Abstract]", "terseLabel": "Cover Page [Abstract]" } } }, "localname": "CoverPageAbstract", "nsuri": "http://healthcarerealty.com/20210601", "xbrltype": "stringItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 14 0000899749-21-000089-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000899749-21-000089-xbrl.zip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end